Observations placeholder

Methylprednisolone is a synthetic glucocorticoid or corticosteroid drug. It is marketed in the USA and Canada under the brand names Medrol and Solu-Medrol. It is also available as a generic drug.  Long-term use of methylprednisolone, as with all corticosteroids, can be associated with hyperglycemia, decreased resistance to infection, swelling of face, weight gain, congestive cardiac insufficiency, fluid and sodium retention, edema, hypertension, increased eye pressure, glaucoma, osteoporosis, and psychosis, especially when used at high doses.

The most serious side effect occurs after the adrenal glands cease natural production of cortisol, which methylprednisolone will replace. Abrupt cessation of the drug after this occurs can result in a condition known as Addisonian crisis, which can be fatal. To prevent this, the drug is usually prescribed with a tapering dose, including a predosed "dose pack" detailing a specific number of tablets to take at designated times over a several-day period. Pharmacists sometimes advise that this drug may cause sleeplessness and "down" moods.

On Jan, 7, 2016: 1,038 people reported to have side effects when taking Methylprednisolone acetate. Among them, 16 people (1.35%) have Hallucination.

Time on Methylprednisolone acetate when people have Hallucination  :

On Jan, 7, 2016: 2,355 people reported to have side effects when taking Methylprednisolone sodium succinate. Among them, 11 people (0.47%) have Hallucination.

Time on Methylprednisolone sodium succinate when people have Hallucination  :

On Jan, 7, 2016: 1,038 people reported to have side effects when taking Methylprednisolone acetate. Among them, 21 people (2.02%) have Death.

Time on Methylprednisolone acetate when people have Death  :

On Jan, 7, 2016: 2,355 people reported to have side effects when taking Methylprednisolone sodium succinate. Among them, 18 people (0.76%) have Death.

Time on Methylprednisolone sodium succinate when people have Death  :